4//SEC Filing
Ryali Sriram 4
Accession 0001209191-19-048805
CIK 0001305253other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 5:47 PM ET
Size
4.8 KB
Accession
0001209191-19-048805
Insider Transaction Report
Form 4
Ryali Sriram
Chief Financial Officer
Transactions
- Award
Common Stock
2019-09-05$9.37/sh+149$1,396→ 1,399 total
Footnotes (1)
- [F1]These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001762893
Filing Metadata
- Form type
- 4
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 5:47 PM ET
- Size
- 4.8 KB